首页 >>2014年06期
肠道病毒71型疫苗使用策略
作者:许文波 檀晓娟

摘要:

关键词:

Abstract:

Key words:

发表日期:2014/6

引用本文:

图/表:

    暂无图表

参考文献:

[1]MirandA, HenquellC, ArchimbaudC, et al. Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France:a large citywide, prospective observational study[J]. Clin MicrobiolInfect, 2012, 18(5):E110–118.
[2]RobinsonCR, DoaneFW, RhodesAJ. Report of an outbreak of febrile illness with pharyngeal lesions and exanthem:Toronto, summer 1957; isolation of group A Coxsackie virus[J]. Can Med Assoc J, 1958, 79(8):615–621.
[3]AlsopJ, FlewettTH, FosterJR. ”Hand–foot–and–mouth disease” in Birmingham in 1959[J]. Br Med J, 1960, 2(5214):1708–1711.
[4]AbuBakarS, CheeHY, Al–KobaisMF, et al. Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease(HFMD)with fatal cases of encephalomyelitis in Malaysia[J]. Virus Res, 1999, 61(1):1–9.
[5]HoM, ChenER, HsuKH, et al. An epidemic of enterovirus 71 infection in Taiwan[J]. N Engl J Med, 1999, 341(13):929–935.
[6]ChenKT, ChangHL, WangST, et al. Epidemiologic features of hand–foot–mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998–2005[J]. Pediatrics, 2007, 120(2):e244–252.
[7]KhanhTH, SabanathanS, ThanhTT, et al. Enterovirus 71–associated hand, foot, and mouth disease, Southern Vietnam, 2011[J]. Emerg Infect Dis, 2012, 18(12):2002–2005.
[8]SeiffA. Cambodia unravels cause of mystery illness[J]. Lancet, 2012, 380(9838):206.
[9]ZhangY, ZhuZ, YangW, et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China[J]. Virol J, 2010, 7:94.
[10]TanX, HuangX, ZhuS, et al. The persistent circulation of enterovirus 71 in People′s Republic of China:causing emerging nationwide epidemics since 2008[J]. PLoS One, 2011, 6(9):e25662.
[11]XingW, LiaoQ, ViboudC, et al. Hand, foot, and mouth disease in China, 2008–12:an epidemiological study[J]. Lancet Infect Dis, 2014, 14(4):308–318.
[12]ZhuF, XuW, XiaJ, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China[J]. N Engl J Med, 2014, 370(9):818–828.
[13]LiR, LiuL, MoZ, et al. An inactivated enterovirus 71 vaccine in healthy children[J]. N Engl J Med, 2014, 370(9):829–837.
[14]ZhuFC, MengFY, LiJX, et al. Efficacy, safety, and immunology of an inactivated alum–adjuvant enterovirus 71 vaccine in children in China:a multicentre, randomised, double–blind, placebo–controlled, phase 3 trial[J]. Lancet, 2013, 381(9882):2024–2032.
[15]ZhangY, TanXJ, WangHY, et al. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China[J]. J Clin Virol, 2009, 44(4):262–267.

用户评论 0条

用户名: 密码: 登陆 注册
 
  • 9
  • 3
  •  4 : 页次:0/0页 共0条记录 5条/每页
    关于我们 | 专家风采 | 会员注册 | 继续教育
    地 址:北京市西城区东河沿街69号正弘大厦511室 邮 编:100052
    电话:010-51322302
    版权所有 中华医学会及中华预防医学杂志编辑部
    京ICP备 07035254 号